168 related articles for article (PubMed ID: 24673472)
1. Basophilic inclusions and neuronal intermediate filament inclusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Ito H
Neuropathology; 2014 Dec; 34(6):589-95. PubMed ID: 24673472
[TBL] [Abstract][Full Text] [Related]
2. Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study.
Yokota O; Tsuchiya K; Terada S; Ishizu H; Uchikado H; Ikeda M; Oyanagi K; Nakano I; Murayama S; Kuroda S; Akiyama H
Acta Neuropathol; 2008 May; 115(5):561-75. PubMed ID: 18080129
[TBL] [Abstract][Full Text] [Related]
3. An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions.
Matsuoka T; Fujii N; Kondo A; Iwaki A; Hokonohara T; Honda H; Sasaki K; Suzuki SO; Iwaki T
Neuropathology; 2011 Feb; 31(1):71-6. PubMed ID: 20573033
[TBL] [Abstract][Full Text] [Related]
4. FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy.
Page T; Gitcho MA; Mosaheb S; Carter D; Chakraverty S; Perry RH; Bigio EH; Gearing M; Ferrer I; Goate AM; Cairns NJ; Thorpe JR
J Mol Neurosci; 2011 Nov; 45(3):409-21. PubMed ID: 21603978
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic variability within the inclusion body spectrum of basophilic inclusion body disease and neuronal intermediate filament inclusion disease in frontotemporal lobar degenerations with FUS-positive inclusions.
Gelpi E; Lladó A; Clarimón J; Rey MJ; Rivera RM; Ezquerra M; Antonell A; Navarro-Otano J; Ribalta T; Piñol-Ripoll G; Pérez A; Valldeoriola F; Ferrer I
J Neuropathol Exp Neurol; 2012 Sep; 71(9):795-805. PubMed ID: 22892522
[TBL] [Abstract][Full Text] [Related]
6. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.
Lashley T; Rohrer JD; Bandopadhyay R; Fry C; Ahmed Z; Isaacs AM; Brelstaff JH; Borroni B; Warren JD; Troakes C; King A; Al-Saraj S; Newcombe J; Quinn N; Ostergaard K; Schrøder HD; Bojsen-Møller M; Braendgaard H; Fox NC; Rossor MN; Lees AJ; Holton JL; Revesz T
Brain; 2011 Sep; 134(Pt 9):2548-64. PubMed ID: 21752791
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathological subtypes of FTLD-FUS.
Mackenzie IR; Munoz DG; Kusaka H; Yokota O; Ishihara K; Roeber S; Kretzschmar HA; Cairns NJ; Neumann M
Acta Neuropathol; 2011 Feb; 121(2):207-18. PubMed ID: 21052700
[TBL] [Abstract][Full Text] [Related]
8. FUS pathology in basophilic inclusion body disease.
Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
[TBL] [Abstract][Full Text] [Related]
9. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
[TBL] [Abstract][Full Text] [Related]
10. An autopsy case report of neuronal intermediate filament inclusion disease presenting with predominantly upper motor neuron features.
Murakami A; Nakamura M; Nakamura Y; Kaneko S; Yakushiji Y; Kusaka H
Neuropathology; 2021 Oct; 41(5):357-365. PubMed ID: 34309938
[TBL] [Abstract][Full Text] [Related]
11. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies.
Koga S; Murakami A; Soto-Beasley AI; Walton RL; Baker MC; Castanedes-Casey M; Josephs KA; Ross OA; Dickson DW
Acta Neuropathol Commun; 2023 Jul; 11(1):109. PubMed ID: 37415197
[TBL] [Abstract][Full Text] [Related]
12. An autopsy case of neuronal intermediate filament inclusion disease with regard to immunophenotypic and topographical analysis of the neuronal inclusions.
Inoue K; Fujimura H; Ueda K; Matsumura T; Itoh K; Sakoda S
Neuropathology; 2015 Dec; 35(6):545-52. PubMed ID: 26096780
[TBL] [Abstract][Full Text] [Related]
13. Neuronal intermediate filament inclusion disease may be incorrectly classified as a subtype of FTLD-FUS.
Bieniek KF; Josephs KA; Lin WL; Dickson DW
Free Neuropathol; 2020; 1():. PubMed ID: 34386806
[TBL] [Abstract][Full Text] [Related]
14. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease.
Neumann M; Roeber S; Kretzschmar HA; Rademakers R; Baker M; Mackenzie IR
Acta Neuropathol; 2009 Nov; 118(5):605-16. PubMed ID: 19669651
[TBL] [Abstract][Full Text] [Related]
15. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Takeda T
Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
[TBL] [Abstract][Full Text] [Related]
16. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
17. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
[TBL] [Abstract][Full Text] [Related]
18. Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).
Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
J Neural Transm (Vienna); 2011 Nov; 118(11):1651-7. PubMed ID: 21792670
[TBL] [Abstract][Full Text] [Related]
19. Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease.
Mosaheb S; Thorpe JR; Hashemzadeh-Bonehi L; Bigio EH; Gearing M; Cairns NJ
Acta Neuropathol; 2005 Oct; 110(4):360-8. PubMed ID: 16025283
[TBL] [Abstract][Full Text] [Related]
20. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
